Detalhe da pesquisa
1.
Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE).
Ann Rheum Dis
; 80(7): 954-955, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619162